GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,687,000 | -12.8% | 61,732 | -12.8% | 0.79% | +30.4% |
| Q1 2022 | $3,082,000 | +7.2% | 70,762 | +8.6% | 0.61% | +0.5% |
| Q4 2021 | $2,874,000 | +15.8% | 65,177 | +0.4% | 0.60% | +16.3% |
| Q3 2021 | $2,481,000 | +4.8% | 64,931 | +9.2% | 0.52% | +7.4% |
| Q2 2021 | $2,367,000 | +24.1% | 59,441 | +11.2% | 0.48% | +4.1% |
| Q1 2021 | $1,907,000 | +23.0% | 53,436 | +26.8% | 0.46% | +13.1% |
| Q4 2020 | $1,551,000 | -4.4% | 42,143 | -6.0% | 0.41% | -11.0% |
| Q3 2020 | $1,622,000 | -12.2% | 44,830 | -1.0% | 0.46% | -27.6% |
| Q2 2020 | $1,848,000 | -7.8% | 45,293 | -3.6% | 0.64% | -24.7% |
| Q1 2020 | $2,004,000 | +12.8% | 47,001 | +24.4% | 0.85% | +37.1% |
| Q4 2019 | $1,776,000 | – | 37,796 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |